RS12208357 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| X-11381 levels | T | OR: 0.32 | 7E-66 | PubMed |
| 3-methylglutarylcarnitine (2) levels | T | OR: 0.31 | 1E-59 | PubMed |
| X-24422 levels | T | OR: 0.31 | 3E-57 | PubMed |
| Isobutyrylcarnitine (C4) levels | T | OR: 0.46 | 4E-54 | PubMed |
| Apolipoprotein B levels | C | β: 0.063 | 5E-54 | PubMed |
| Plasma isobutyrylcarnitine (C4) levels in chronic kidney disease | T | OR: 0.42 | 2E-52 | PubMed |
| Direct low density lipoprotein levels (UKB data field 30780) | T | β: 0.055 | 2E-52 | PubMed |
| LDL cholesterol levels | C | β: 0.057 | 3E-44 | PubMed |
| Phospholipids in very small VLDL | T | β: 0.06 | 2E-43 | PubMed |
| Concentration of very small VLDL particles | T | β: 0.06 | 1E-42 | PubMed |
| Total lipids in very small VLDL | T | β: 0.05 | 3E-42 | PubMed |
| Free cholesterol in very small VLDL | T | β: 0.05 | 8E-40 | PubMed |
| Citrate levels | T | β: 0.05 | 6E-39 | PubMed |
| Cholesterol levels in very small VLDL | T | β: 0.05 | 6E-35 | PubMed |
| Plasma X-17323 levels in chronic kidney disease | T | OR: 0.3 | 3E-34 | PubMed |
| Concentration of IDL particles | T | β: 0.05 | 1E-32 | PubMed |
| Cholesterol esters in very small VLDL | T | β: 0.05 | 5E-32 | PubMed |
| Concentration of large LDL particles | T | β: 0.05 | 8E-32 | PubMed |
| Urine X-17323 levels in chronic kidney disease | T | OR: 0.35 | 9E-30 | PubMed |
| X-11381 levels | T | OR: 0.31 | 2E-29 | PubMed |